HU-336

HU-336 is a synthetic cannabinoid that has been shown to inhibit the growth of cancer cells in vitro. It is a derivative of cannabidiol, a non-psychoactive compound found in cannabis. HU-336 has been studied for its potential use in the treatment of cancer.

Chemistry

HU-336 is a synthetic cannabinoid, which means it is a chemical compound that has been designed to mimic the effects of naturally occurring cannabinoids. It is a derivative of cannabidiol, which is one of the many compounds found in the cannabis plant. The "HU" in its name stands for Hebrew University, where the compound was first synthesized.

Pharmacology

The exact mechanism of action of HU-336 is not fully understood. However, it is known that it interacts with the cannabinoid receptors in the body, which are part of the endocannabinoid system. This system plays a role in a variety of physiological processes, including pain sensation, mood, and memory.

Medical uses

HU-336 has been studied for its potential use in the treatment of cancer. In vitro studies have shown that it can inhibit the growth of cancer cells. However, more research is needed to determine whether it could be used as a treatment in humans.

See also

• Cannabinoid
• Cannabidiol
• Cancer

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• HU-336
  HU-336